Accendra Health, Inc. ACH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -7.14% | -3.30% | -0.01% | 3.06% | -40.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.14% | -3.30% | -0.01% | 3.06% | -40.79% |
| Cost of Revenue | -1.61% | 2.19% | 3.65% | 5.22% | -53.61% |
| Gross Profit | -13.32% | -9.30% | -4.00% | 0.70% | -14.39% |
| SG&A Expenses | -4.18% | -3.23% | -1.15% | -1.21% | -16.03% |
| Depreciation & Amortization | 77.70% | 273.87% | 181.55% | 80.65% | -1.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.06% | 3.25% | 3.99% | 3.67% | -42.33% |
| Operating Income | -93.43% | -84.31% | -52.65% | -6.85% | -4.72% |
| Income Before Tax | 62.46% | 70.50% | 64.30% | 69.09% | -5,680.46% |
| Income Tax Expenses | -188.45% | -118.25% | -129.62% | -96.50% | 604.79% |
| Earnings from Continuing Operations | 71.08% | 73.56% | 69.12% | 70.72% | -38,900.00% |
| Earnings from Discontinued Operations | 94.69% | 75.59% | -3,865.85% | -8,250.43% | -1,819.14% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 87.20% | 74.88% | -195.84% | -203.47% | -2,647.63% |
| EBIT | -93.43% | -84.31% | -52.65% | -6.85% | -4.72% |
| EBITDA | -51.10% | -43.28% | -36.35% | -27.72% | -4.20% |
| EPS Basic | 87.15% | 74.88% | -196.47% | -203.85% | -2,639.45% |
| Normalized Basic EPS | -586.78% | -291.87% | -182.95% | -2.74% | -65.09% |
| EPS Diluted | 87.12% | 74.85% | -196.40% | -203.83% | -2,629.33% |
| Normalized Diluted EPS | -586.78% | -293.32% | -183.51% | -0.84% | -64.41% |
| Average Basic Shares Outstanding | -0.62% | -0.44% | -0.29% | 0.29% | 0.73% |
| Average Diluted Shares Outstanding | -0.62% | -0.88% | -0.74% | -0.16% | -0.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |